The Oral Cancer Treatment Market, valued at $1.8 billion in 2021, is projected to grow at a CAGR of 5.8%, reaching $3.8 billion by 2028. Geographically, North America leads due to higher drug affordability and rising oral cancer cases. Asia-Pacific is expected to witness the highest growth, driven by increasing healthcare infrastructure investment and rising tobacco consumption.